HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Baragi, V. M. Articles by Welgus, H. G. Search for Related Content PubMed PubMed Citation Articles by Baragi, V. M. Articles by Welgus, H. G. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 269, Issue 17, 12692-12697, Apr, 1994

Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysin

VM Baragi, CJ Fliszar, MC Conroy, QZ Ye, JM Shipley and HG Welgus
Department of Immunopathology, Parke-Davis Pharmaceutical Research, Warner-Lambert Company, Ann Arbor, Michigan 48105.

In this study, we have used high resolution gel-filtration chromatography and measurements of Ki to compare the capacity of full- length native stromelysin, C-terminal truncated stromelysin (Phe100- Pro273), and matrilysin (the only metalloproteinase spontaneously lacking a C-terminal hemopexin-like domain) to bind to the tissue inhibitor of metalloproteinases (TIMP). While prostromelysin failed to bind TIMP, active stromelysin bound to the inhibitor avidly, exhibiting an affinity for TIMP (Ki = 8.3 x 10(-10) M) essentially identical to that of active interstitial collagenase as determined by competition experiments. C-terminal truncated stromelysin also formed a higher M(r) complex with TIMP which survived gel filtration. However, when truncated stromelysin was forced to compete with its full-length parent molecule for limiting amounts of TIMP, the full-length enzyme preferentially bound to the inhibitor. Indeed, binding studies indicated a Ki of 5.95 x 10(-9) M for the truncated variant's interaction with TIMP, only 14% as tight as that of full-length stromelysin. We also examined the interaction between TIMP and matrilysin, the only metalloproteinase which naturally lacks a C- terminal domain. Promatrilysin failed to bind the inhibitor. However, active matrilysin readily bound TIMP, forming a complex that resisted separation by gel filtration. When active matrilysin was forced to compete with truncated stromelysin for limiting amounts of TIMP, both enzymes appeared to complex the inhibitor with nearly equivalent efficacy. Indeed, active matrilysin exhibited a Ki for TIMP of 4.5 x 10(-9) M, essentially identical to that of truncated stromelysin. These data indicate that, as is true for collagenase, the C-terminal domain of stromelysin contributes significantly to its capacity to bind the physiologic inhibitor, TIMP. Furthermore, since stromelysin readily processes in vitro to a C-terminal truncated form, this enzyme species, as well as the full-length metalloproteinase matrilysin, may resist inhibition by TIMP in areas of active inflammation in vivo.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. Chen, J. K. McGuire, R. C. Hackman, K.-H. Kim, R. A. Black, K. Poindexter, W. Yan, P. Liu, A. J. Chen, W. C. Parks, et al. Tissue Inhibitor of Metalloproteinase-1 Moderates Airway Re-Epithelialization by Regulating Matrilysin Activity Am. J. Pathol., May 1, 2008; 172(5): 1256 - 1270. [Abstract] [Full Text] [PDF]

				P. Vempati, E. D. Karagiannis, and A. S. Popel A Biochemical Model of Matrix Metalloproteinase 9 Activation and Inhibition J. Biol. Chem., December 28, 2007; 282(52): 37585 - 37596. [Abstract] [Full Text] [PDF]

				A. Riccioli, V.D. Secco, P.D. Cesaris, D. Starace, L. Gandini, A. Lenzi, F. Dondero, F. Padula, A. Filippini, and E. Ziparo Presence of membrane and soluble forms of Fas ligand and of matrilysin (MMP-7) activity in normal and abnormal human semen Hum. Reprod., October 1, 2005; 20(10): 2814 - 2820. [Abstract] [Full Text] [PDF]

				K. M. Smith, A. Gaultier, H. Cousin, D. Alfandari, J. M. White, and D. W. DeSimone The cysteine-rich domain regulates ADAM protease function in vivo J. Cell Biol., December 9, 2002; 159(5): 893 - 902. [Abstract] [Full Text] [PDF]

				K. Yamashita, M. Mori, T. Shiraishi, K. Shibuta, and K. Sugimachi Clinical Significance of Matrix Metalloproteinase-7 Expression in Esophageal Carcinoma Clin. Cancer Res., March 1, 2000; 6(3): 1169 - 1174. [Abstract] [Full Text]

				Y Adachi, H Yamamoto, F Itoh, Y Hinoda, Y Okada, and K Imai Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers Gut, August 1, 1999; 45(2): 252 - 258. [Abstract] [Full Text] [PDF]

				L. A. Cornelius, L. C. Nehring, E. Harding, M. Bolanowski, H. G. Welgus, D. K. Kobayashi, R. A. Pierce, and S. D. Shapiro Matrix Metalloproteinases Generate Angiostatin: Effects on Neovascularization J. Immunol., December 15, 1998; 161(12): 6845 - 6852. [Abstract] [Full Text] [PDF]

				K. B. Taylor, L. J. Windsor, N. C.M. Caterina, M. K. Bodden, and J. A. Engler The Mechanism of Inhibition of Collagenase by TIMP-1 J. Biol. Chem., September 27, 1996; 271(39): 23938 - 23945. [Abstract] [Full Text] [PDF]

				S. D. Shapiro, C. J. Fliszar, T. J. Broekelmann, R. P. Mecham, R. M. Senior, and H. G. Welgus Activation of the 92-kDa Gelatinase by Stromelysin and 4-Aminophenylmercuric Acetate J. Biol. Chem., March 17, 1995; 270(11): 6351 - 6356. [Abstract] [Full Text] [PDF]